ALLOGENE THERAPEUTICS INC's ticker is ALLO and the CUSIP is 019770106. A total of 160 filers reported holding ALLOGENE THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 0.17 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $210,728 | +105.1% | 42,400 | +103.8% | 0.00% | – |
| Q1 2023 | $102,752 | -54.5% | 20,800 | -0.5% | 0.00% | – |
| Q3 2022 | $226,000 | -56.2% | 20,900 | -53.8% | 0.00% | – |
| Q2 2022 | $516,000 | +24.9% | 45,285 | 0.0% | 0.00% | – |
| Q1 2022 | $413,000 | -49.6% | 45,285 | -17.0% | 0.00% | -100.0% |
| Q4 2021 | $819,000 | +99.8% | 54,585 | +241.9% | 0.00% | – |
| Q3 2021 | $410,000 | -1.4% | 15,965 | 0.0% | 0.00% | – |
| Q2 2021 | $416,000 | -38.4% | 15,965 | -10.8% | 0.00% | -100.0% |
| Q3 2020 | $675,000 | -19.4% | 17,895 | -8.4% | 0.00% | 0.0% |
| Q2 2020 | $837,000 | – | 19,538 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Vida Ventures Advisors, LLC | 1,798,163 | $5,700,177 | 8.82% |
| Wildcat Capital Management, LLC | 1,920,787 | $6,088,895 | 2.44% |
| TPG GP A, LLC | 18,716,306 | $59,330,690 | 1.02% |
| EcoR1 Capital, LLC | 4,488,200 | $14,227,594 | 0.48% |
| CROSSPOINT FINANCIAL, LLC | 12,000 | $38,040 | 0.40% |
| Coastal Bridge Advisors, LLC | 406,847 | $1,289,705 | 0.35% |
| CAXTON ASSOCIATES LP | 480,104 | $1,521,930 | 0.21% |
| Woodline Partners LP | 5,313,915 | $16,845,111 | 0.20% |
| Rhenman & Partners Asset Management AB | 300,000 | $951,000 | 0.10% |
| Navalign, LLC | 75,365 | $238,907 | 0.09% |